Coughlin, C.R., Swanson, M.A., Spector, E. et al. The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: a common epileptic encephalopathy. J Inherit Metab Dis (2018). https://doi-org.ezp3.lib.umn.edu/10.1007/s10545-018-0219-7
Abstract
Pyridoxine dependent epilepsy (PDE) is a treatable epileptic
encephalopathy characterized by a positive response to pharmacologic doses of
pyridoxine. Despite seizure control, at least 75% of individuals have
intellectual disability and developmental delay. Current treatment paradigms
have resulted in improved cognitive outcomes emphasizing the importance of an
early diagnosis. As genetic testing is increasingly accepted as first tier
testing for epileptic encephalopathies, we aimed to provide a comprehensive
overview of ALDH7A1 mutations that cause PDE. The genotypes, ethnic origin, and
reported gender was collected from 185 subjects with a diagnosis of PDE. The
population frequency for the variants in this report and the existing
literature were reviewed in the Genome Aggregation Database (gnomAD). Novel
variants identified in population databases were also evaluated through in
silico prediction software and select variants were over-expressed in an
E.coli-based expression system to measure α-aminoadipic semialdehyde
dehydrogenase activity and production of α-aminoadipic acid. This study adds 47
novel variants to the literature resulting in a total of 165 reported
pathogenic variants. Based on this report, in silico predictions, and general
population data, we estimate an incidence of approximately 1:64,352 live
births. This report provides a comprehensive overview of known ALDH7A1
mutations that cause PDE, and suggests that PDE may be more common than
initially estimated. Due to the relative high frequency of the disease, the
likelihood of under-diagnosis given the wide clinical spectrum and limited
awareness among clinicians as well as the cognitive improvement noted with early
treatment, newborn screening for PDE may be warranted.
No comments:
Post a Comment